Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Highly Specific Interventions.......

<< Previous

Bullboard Posts

Next >>

Comment by silentrunningon Jan 24, 2021 5:04pm

85 Views

Post# 32371765

RE:RE:RE:Highly Specific Interventions.......

This could be outlandishly phenomenal Blig. Best to everyone.

bligicka wrote: Ya Dr Stickler is a huge advacate of peptides...I love that he said he has more peptides in his fridge than food ...lol !!!

He also called peptides "cool stuff", just like Jason our interviewer ....lol !!!

So now that I know someone has a patent on "cognitive enhancing peptides" I think I might invest there as well........ (how do I get some of these pills ???)

Theirs going to be a rush to patent these important peptides and Vaxil's already got solid intellectual property locked down !!!

Peptide patent portfolio !!!